- Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept
-
Baum RP, Langbein T, Singh A, Shahinfar , Schuchardt C, Volk GF, Kulkarni H
- KMID: 2407306
- Nucl Med Mol Imaging.
- 2018 Feb;52(1):80-81.
- doi: 10.1007/s13139-017-0508-3
The dose-limiting salivary gland toxicity of ²²âµAc-labelled PSMA for treatment of metastatic, castration-resistant prostate cancer remains unresolved. Suppressing the metabolism of the gland by intraparenchymal injections of botulinum toxin appears... -
- CITED
-
- Close
- SHARE
-
- Close
- Systemic Endoradiotherapy with Carrier-Added 4-[131I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory Glioma
-
Baum RP, Kluge A, Gildehaus , Bronzel M, Schmidt K, Schuchardt C, Senftleben S, Samnick S
- KMID: 1447626
- Nucl Med Mol Imaging.
- 2011 Dec;45(4):299-307.
PURPOSE: To explore feasibility, tolerability, dosimetry and probable efficacy of intravenous endoradiotherapy with carrier-added 4-[131I]iodo-L-phenylalanine (c.a. 131I-IPA) in refractory high-grade glioma. METHODS: Two male patients (45 and 50 years), with longstanding,... -
- CITED
-
- Close
- SHARE
-
- Close
